{"rows":[{"id":2690,"title":"Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.","authors":"Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K","journal":"European archives of psychiatry and clinical neuroscience","publication_date":"2005-10-01","publication_year":2005,"doi":"10.1007/s00406-005-0563-0","pubmed_id":"15834758","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/15834758/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:15834758","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/15834758/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:15834758","source_url":"https://pubmed.ncbi.nlm.nih.gov/15834758/","doi":"10.1007/s00406-005-0563-0","pmid":"15834758","publication_date":"2005-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1125,"title":"Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.","authors":"Iorgu AM, Vasilescu AN, Pfeiffer N, Spanagel R, Mallien AS, Inta D, Gass P","journal":"European archives of psychiatry and clinical neuroscience","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1007/s00406-023-01699-3","pubmed_id":"37934233","openalex_id":"https://openalex.org/W4388460206","source_url":"https://pubmed.ncbi.nlm.nih.gov/37934233/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Biomarkers,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:37934233","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37934233/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37934233","source_url":"https://pubmed.ncbi.nlm.nih.gov/37934233/","doi":"10.1007/s00406-023-01699-3","pmid":"37934233","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":594,"title":"Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?","authors":"Hashimoto K","journal":"European archives of psychiatry and clinical neuroscience","publication_date":"2025-08-01","publication_year":2025,"doi":"10.1007/s00406-024-01770-7","pubmed_id":"38411629","openalex_id":"https://openalex.org/W4392193120","source_url":"https://pubmed.ncbi.nlm.nih.gov/38411629/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Mystical Experience,Clinical Trial,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:38411629","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38411629/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38411629","source_url":"https://pubmed.ncbi.nlm.nih.gov/38411629/","doi":"10.1007/s00406-024-01770-7","pmid":"38411629","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":86,"title":"Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.","authors":"He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J","journal":"European archives of psychiatry and clinical neuroscience","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1007/s00406-025-02165-y","pubmed_id":"41677823","openalex_id":"https://openalex.org/W7128718542","source_url":"https://pubmed.ncbi.nlm.nih.gov/41677823/","substance_tags":"psilocybin","topic_tags":"Depression,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:49","bibtex":null,"source_record_id":"PMID:41677823","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41677823/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41677823","source_url":"https://pubmed.ncbi.nlm.nih.gov/41677823/","doi":"10.1007/s00406-025-02165-y","pmid":"41677823","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":81,"title":"Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.","authors":"Varela YM, de O Tavares VD, Delgado LM, de Faria HAT, Menezes LQ, Almeida RM, Agrícola P, de Carvalho BS, Bienemann B, Falchi-Carvalho M, Cavalcanti-Ribeiro P, Palhano-Fontes F, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho N","journal":"European archives of psychiatry and clinical neuroscience","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1007/s00406-025-02188-5","pubmed_id":"41902950","openalex_id":"https://openalex.org/W7141898289","source_url":"https://pubmed.ncbi.nlm.nih.gov/41902950/","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:49","bibtex":null,"source_record_id":"PMID:41902950","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41902950/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41902950","source_url":"https://pubmed.ncbi.nlm.nih.gov/41902950/","doi":"10.1007/s00406-025-02188-5","pmid":"41902950","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":5,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"European archives of psychiatry and clinical neuroscience","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}